68Ga-Labeled Cyclic NGR Peptide for MicroPET Imaging of CD13 Receptor Expression

68Ga-Labeled Cyclic NGR Peptide for MicroPET Imaging of CD13 Receptor Expression

Peptides containing the asparagines-glycine-arginine (NGR) motif have been identified as specific ligands binding to CD13/aminopeptidase N (APN) receptor, a tumor neovascular biomarker. In this study, we synthesized a novel NGR-containing peptide (NOTA-G3-NGR), and labeled NOTA-G3-NGR with 68Ga (t1/...

Full description

Bibliographic Details
Main Authors:	Yahui Shao, Wansheng Liang, Fei Kang, Weidong Yang, Xiaowei Ma, Guiyu Li, Shu Zong, Kai Chen, Jing Wang
Format:	Article
Language:	English
Published:	MDPI AG 2014-08-01
Series:	Molecules
Subjects:	microPET imaging NGR peptide CD13 tumor angiogenesis 68Ga labeling
Online Access:	http://www.mdpi.com/1420-3049/19/8/11600

Similar Items

Preclinical Assessment Addressing Intravenous Administration of a [<sup>68</sup>Ga]Ga-PSMA-617 Microemulsion: Acute In Vivo Toxicity, Tolerability, PET Imaging, and Biodistribution
by: Vusani Mandiwana, et al.
Published: (2021-04-01)

Imaging angiogenesis in atherosclerosis in large arteries with 68Ga-NODAGA-RGD PET/CT: relationship with clinical atherosclerotic cardiovascular disease
by: Matthieu Dietz, et al.
Published: (2021-08-01)

Mechanism of Action of the Tumor Vessel Targeting Agent NGR-hTNF: Role of Both NGR Peptide and hTNF in Cell Binding and Signaling
by: Barbara Valentinis, et al.
Published: (2019-09-01)

Preclinical validations of [18F]FPyPEGCBT-c(RGDfK): a 18F-labelled RGD peptide prepared by ligation of 2-cyanobenzothiazole and 1,2-aminothiol to image angiogenesis
by: Didier J. Colin, et al.
Published: (2016-10-01)

Estudo de materiais adsorvedores para o preparo de geradores de Ge-68/Ga-68
by: Tânia de Paula Brambilla
Published: (2013)

Estudo de materiais adsorvedores para o preparo de geradores de Ge-68/Ga-68
by: Brambilla, Tânia de Paula
Published: (2013)

pH-Responsive Carboxymethylcellulose Nanoparticles for <sup>68</sup>Ga-WBC Labeling in PET Imaging
by: Anna Maria Piras, et al.
Published: (2019-10-01)

68Ga DOTATATE Uptake in Hemangioma Simulating Metastasis on PET Imaging
by: Bart Vertenten, et al.
Published: (2019-06-01)

Preclinical Evaluation of <sup>68</sup>Ga-labeled RGD Peptide for Detection of Malignant Angiogenesis
by: O. E. Klementyeva, et al.
Published: (2020-08-01)

Importance of Attenuation Correction (AC) for Small Animal PET Imaging
by: Henrik H. El Ali, et al.
Published: (2012-10-01)

Head and neck tumors angiogenesis imaging with 68Ga-NODAGA-RGD in comparison to 18F-FDG PET/CT: a pilot study
by: Steve Durante, et al.
Published: (2020-05-01)

Metastatic urinary bladder paraganglioma on Ga-68 DOTATATE PET/CT
by: Andrew Ko, BSA, et al.
Published: (2021-09-01)

The diagnostic value of PET/CT imaging with the 68Ga-labeled PSMA-ligand in the follow up assessment of prostate cancer after therapy
by: Talaat Ahmed Abd El Hameed Hassan, et al.
Published: (2020-07-01)

Assessment and Use of NGR Instrumentation on the JOIDES Resolution to Quantify U, Th, and K Concentrations in Marine Sediment
by: Ann G. Dunlea, et al.
Published: (2013-03-01)

68Ga-PSMA PET/CT in prostate cancer patients – patterns of disease, benign findings and pitfalls
by: Zohar Keidar, et al.
Published: (2018-11-01)

68Ga-NOTA-Evans Blue PET/CT findings in lymphangioleiomyomatosis compared with 99mTC-ASC lymphoscintigraphy: a prospective study
by: Guozhu Hou, et al.
Published: (2021-06-01)

Möjligheter med MR och 68Ga-DOTATOC PET/DT för att diagnosticera meningiom : En litteraturstudie
by: Mohajer Soltani, Nilofar
Published: (2013)

Incidental prostate-specific membrane antigen-avid meningioma detected on 68Ga–prostate-specific membrane antigen PET/CT
by: James Yuheng Jiang, MD, MMed (ClinEpi), et al.
Published: (2021-11-01)

Preparation and Quality Control of 68Ga-Citrate for PET Applications
by: Ayuob Aghanejad, et al.
Published: (2015-07-01)

Safety assessment of the process ‘Märkische Faser’, based on NGR technology, used to recycle post‐consumer PET into food contact materials
by: Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF), et al.
Published: (2017-07-01)

Application of the 68Ge/68Ga Generator in Clinic
by: HUANG Qian-huan1;PAN Dong-hui2;XU Yu-ping2;SHENG Jie1;WANG Yan-ting2;YANG Min1,2
Published: (2017-04-01)

Otto: a 4.04 GBq (109 mCi) 68Ge/68Ga generator, first of its kind - extended quality control and performance evaluation in the clinical production of [68Ga]Ga-PSMA-11
by: Nicole N. Waterhouse, et al.
Published: (2020-02-01)

Diagnostic utility of 68Ga-citrate and 18FDG PET/CT in sarcoidosis patients
by: Cuneyt Tetikkurt, et al.
Published: (2020-12-01)

In vitro and in vivo evaluation of novel NGR-modified liposomes containing brucine
by: Li S, et al.
Published: (2017-08-01)

Development of novel cyclic NGR peptide–daunomycin conjugates with dual targeting property
by: Andrea Angelo Pierluigi Tripodi, et al.
Published: (2018-04-01)

DATATOC: a novel conjugate for kit-type 68Ga labelling of TOC at ambient temperature
by: Johanna Seemann, et al.
Published: (2016-03-01)

[68Ga]Ga-PSMA-11 PET before and after initial long-term androgen deprivation in patients with newly diagnosed prostate cancer: a retrospective single-center study
by: Sebastian Hoberück, et al.
Published: (2020-11-01)

Optimization of injected 68Ga-PSMA activity based on list-mode phantom data and clinical validation
by: J. Wielaard, et al.
Published: (2020-04-01)

Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG
by: Qingqing Pan, et al.
Published: (2020-08-01)

A 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior
by: Hajdu I, et al.
Published: (2018-11-01)

[68Ga]Ga-PSMA-11 PET/CT for monitoring response to treatment in metastatic prostate cancer: is there any added value over standard follow-up?
by: Jonathan Kuten, et al.
Published: (2019-08-01)

New NGR-targeted shRNA-loaded Liposome Suppresses Glioma Growth
by: ZHAO Guanjian, et al.
Published: (2019-08-01)

The role of 68Ga-DOTA derivatives PET-CT in patients with ectopic ACTH syndrome
by: Filippo Ceccato, et al.
Published: (2020-04-01)

Lesion-to-background ratio threshold value of SUVmax of simultaneous [68Ga]Ga-PSMA-11 PET/MRI imaging in patients with prostate cancer
by: Jing Zhao, et al.
Published: (2020-12-01)

[68Ga]Exendin-4: Bench-to-Bedside : PET molecular imaging of the GLP-1 receptor for diabetes and cancer
by: Selvaraju, Ram kumar
Published: (2015)

Optimized Application of 68Ga-Prostate-Specific Membrane Antigen-617 Whole-Body PET/CT and Pelvic PET/MR in Prostate Cancer Initial Diagnosis and Staging
by: Chunxia Qin, et al.
Published: (2021-05-01)

Incidental Diagnosis of Multiple Paragangliomas by Ga-68 DOTANOC Positron Emission Tomography-Computed Tomography
by: Vivek Saini, et al.
Published: (2021-07-01)

[<sup>68</sup>Ga]Ga-PSMA-11: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
by: Ute Hennrich, et al.
Published: (2021-07-01)

Comparison of the Relative Diagnostic Performance of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers
by: Junhao Wu, et al.
Published: (2021-09-01)

Potential usefulness of 68Ga-citrate PET/CT in detecting infected lower limb prostheses
by: Jing-Ren Tseng, et al.
Published: (2019-01-01)